Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation (NYSE: WAT) is a global company in analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences. This news page aggregates announcements, press releases, and corporate updates related to Waters, giving readers a focused view of developments that affect the company and its markets.
Investors and industry professionals can use this feed to follow Waters’ product launches, financial results, and strategic initiatives. Recent news has highlighted new technologies such as the Xevo Charge Detection Mass Spectrometer (CDMS), which Waters describes as enabling direct mass detection for large biomolecules relevant to next-generation therapeutics, and a Charged Aerosol Detector designed for use with the company’s Empower chromatography data system. These announcements illustrate how Waters is addressing analytical challenges in pharmaceuticals, biotherapeutics, food analysis, and environmental testing.
The news stream also features quarterly earnings releases, where Waters reports sales performance, instrument and recurring revenue trends, and commentary from management. In addition, Waters issues updates on investor conference presentations and on the planned combination with BD’s Biosciences & Diagnostic Solutions business via a Reverse Morris Trust transaction, as described in its press releases and Form 8-K filings.
By reviewing Waters-related news in one place, readers can track themes such as instrument replacement cycles, adoption of new chromatography and mass spectrometry products, and the company’s expansion into adjacencies like bioseparations, bioanalytical characterization, and multiplex diagnostics. Bookmark this page to monitor ongoing disclosures and media releases that shape the narrative around WAT stock and Waters’ role in regulated, high-volume testing and scientific markets.
Waters Corporation (NYSE:WAT) introduced the Xevo G3 quadrupole time-of-flight mass spectrometer, boasting up to 10X more sensitivity than its predecessor. The launch, announced at the ASMS 2022 Annual Conference, aims to enhance drug discovery and development. Additionally, the new CONFIRM Sequence app streamlines nucleic acid sequencing confirmation, cutting data review time by 50%. Finally, the integration of a new electrospray ionization source with the SELECT SERIES MRT system enables rapid molecular characterization.
Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., President and CEO, will engage in a fireside chat at the Jefferies 2022 Global Healthcare Conference in New York City on June 8th, 2022, at 4:30 PM EST. Interested investors can access the live webcast via Waters' investor relations website, which will be available for replay for 30 days. Waters has been a leader in analytical instruments for over 60 years, operating in 35 countries with a workforce exceeding 7,800 employees.
Waters Corporation (NYSE: WAT) has inaugurated its latest innovation lab, Immerse™ Delaware, at the University of Delaware's STAR campus. This facility aims to tackle major challenges in the biopharmaceutical industry by fostering collaboration between students, faculty, and industry partners. The lab is a product of a multi-year partnership established in October 2021, focusing on improving biotherapeutic development and manufacturing processes.
Waters Corporation (NYSE: WAT) reported first quarter 2022 sales of $691 million, marking a 13% increase year-over-year and a 16% rise in constant currency. Instrument sales surged 26% in constant currency, driven by strong performance across key product lines. The company achieved a GAAP EPS of $2.62 and a non-GAAP EPS of $2.80, reflecting a 22% increase compared to the previous year. Waters raised its 2022 guidance for sales growth to 7.5% to 9% and non-GAAP EPS to $11.90 to $12.10 amid positive customer feedback for new product launches.
Waters Corporation (NYSE:WAT) will host its 2022 Investor Day on May 19, 2022, starting at 8:45 a.m. ET at the New York Stock Exchange in New York, NY. The event includes presentations by senior management and a Q&A session. A live webcast will be available on Waters’ investor relations website, with a replay offered later. Waters Corporation is a leader in analytical instruments and software, serving various scientific fields for over 60 years, operating in 35 countries, and employing over 7,800 people globally.
Waters Corporation (NYSE:WAT) is set to host a live webcast of its Q1 2022 financial results conference call on May 3, 2022, at 8:00 a.m. Eastern Time. Interested parties can access the live presentation via Waters' investor relations website. A replay will be available until May 17, 2022, at midnight Eastern Time. Waters is renowned for its innovations in chromatography, mass spectrometry, and thermal analysis, with over 7,400 employees operating in 35 countries.
Waters Corporation (NYSE:WAT) has launched the Xevo TQ Absolute, advancing mass spectrometry technology. This new tandem quadrupole mass spectrometer is up to 15X more sensitive in quantifying negatively ionized compounds and 45% smaller than its competitors, using 50% less power and nitrogen. Designed for various analytical laboratories, it aims to enhance productivity and support sustainability goals. Shipments are expected to begin in May.
Waters Corporation (NYSE:WAT) has launched the Intact Mass application on the waters_connect platform, enabling faster and simplified biomolecule analysis. This software can confirm the mass and purity of biomolecules nearly twice as fast as existing options. The app is available as an upgrade for new and installed BioAccord LC-MS systems. Additionally, the introduction of Waters MaxPeak Premier columns enhances sensitivity by 2x to 3x compared to conventional steel columns, facilitating effective drug discovery processes.
Waters Corporation (NYSE:WAT) announced that its CEO, Udit Batra, will participate in a fireside chat at the Cowen Healthcare Conference on March 9, 2022, at 2:10 PM EST. Investors can access the live webcast on Waters’ investor relations website, with a replay available for 30 days. Waters Corporation has been a leader in chromatography, mass spectrometry, and thermal analysis for over 60 years, employing over 7,400 people globally and operating in 35 countries.
Waters Corporation (NYSE:WAT) will have its SVP & Chief Financial Officer, Amol Chaubal, participate in a virtual fireside chat at Citi’s 2022 Virtual Healthcare Conference on February 24 at 3:30 PM ET. Investors can access the live webcast through Waters’ investor relations website, with a replay available for 30 days. Waters Corporation is recognized for pioneering innovations in chromatography, mass spectrometry, and thermal analysis, serving various sectors for over 60 years, and operates in 35 countries with more than 7,400 employees.